Ligand · GHC
GHC · N-({4-[(2-amino-6-ethyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-5-yl)sulfanyl]phenyl}carbonyl)-L-glutamic acid
GHC, N-({4-[(2-amino-6-ethyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-5-yl)sulfanyl]phenyl}carbonyl)-L-glutamic acid (C20 H20 N4 O6 S2, 476.5 g/mol), in the MolNFT structures on GenesisL1: bound in 4 records (2 PDB entries). Every binding…
- Component
- GHC
- Formula
- C20 H20 N4 O6 S2
- Class
- ligand
- Structures
- 4
- PDB entries
- 2
Binding sites
GHC in 4 structures; the first of them:
- 3GHC · Design, Synthesis, and X-ray Crystal Structure of Classical and Nonclassical… · GHC A187 · binds ILE7, VAL8, ALA9, LEU22, GLU30, PHE31, ARG32, PHE34 and 11 more
- 3GHV · Human dihydrofolate reductase Q35K/N64F double mutant inhibitor complex · GHC A187 · binds ILE7, VAL8, ALA9, LEU22, GLU30, PHE31, PHE34, LYS35 and 9 more
- 3GHC · Design, synthesis, and X-ray crystal structure of classical and nonclassical… · GHC A187 · binds ILE7, VAL8, ALA9, LEU22, GLU30, PHE31, ARG32, PHE34 and 11 more
- 3GHV · Human dihydrofolate reductase Q35K/N64F double mutant inhibitor complex · GHC A187 · binds ILE7, VAL8, ALA9, LEU22, GLU30, PHE31, PHE34, LYS35 and 9 more
Residues it binds most
PHE 4, ILE 4, LEU 4, THR 4, VAL 4, ARG 4, ALA 4, GLU 4, LYS 4, PRO 4 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.